Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Valeant to pay $318mm for Aton Pharma

Executive Summary

In its fourth acquisition so far this year, Valeant Pharmaceuticals International (brand, generic, and OTC products) has paid $318mm in cash for private specialty pharmaco Aton Pharma Inc. The deal was announced along with Valeant's first quarter earnings results, which showed double-digit percent increases in total revenue and income compared with Q1 2009.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies